{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:00:20Z","timestamp":1785535220288,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jinf.2023.10.022","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T22:35:10Z","timestamp":1699050910000},"page":"30-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effectiveness of BNT162b2 mRNA vaccine third doses and previous infection in protecting against SARS-CoV-2 infections during the Delta and Omicron variant waves; the UK SIREN cohort study September 2021 to February 2022"],"prefix":"10.1016","volume":"88","author":[{"given":"Victoria J.","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4881-8138","authenticated-orcid":false,"given":"Ferdinando","family":"Insalata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Foulkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6904-0500","authenticated-orcid":false,"given":"Peter","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8475-3864","authenticated-orcid":false,"given":"Dominic","family":"Sparkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Atti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elen","family":"de Lacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5678-4818","authenticated-orcid":false,"given":"Lesley","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Corrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Charlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2023.10.022_bib1","unstructured":"Edouard Mathieu HR, Lucas Rod\u00e9s-Guirao, Cameron Appel, Charlie Giattino, Joe Hasell, Bobbie Macdonald, Saloni Dattani, Diana Beltekian, Esteban Ortiz-Ospina, Max Roser. Coronavirus Pandemic (COVID-19); 2020. \u3008https:\/\/ourworldindata.org\/coronavirus\u3009. [Accessed 12.10.2023 2023]."},{"key":"10.1016\/j.jinf.2023.10.022_bib2","unstructured":"JCVI. JCVI statement regarding a COVID-19 booster vaccine programme for winter 2021 to 2022; 2021. \u3008https:\/\/www.gov.uk\/government\/publications\/jcvi-statement-september-2021-covid-19-booster-vaccine-programme-for-winter-2021-to-2022\/jcvi-statement-regarding-a-covid-19-booster-vaccine-programme-for-winter-2021-to-2022#fn:1\u3009. Accessed 01\/02\/2023."},{"issue":"4","key":"10.1016\/j.jinf.2023.10.022_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMoa2115481","article-title":"Duration of protection against mild and severe disease by Covid-19 vaccines","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jinf.2023.10.022_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30895-3","article-title":"Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar","volume":"13","author":"Chemaitelly","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jinf.2023.10.022_bib5","article-title":"Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study","volume":"376","author":"Lauring","year":"2022","journal-title":"BMJ"},{"issue":"13","key":"10.1016\/j.jinf.2023.10.022_bib6","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1056\/NEJMc2200133","article-title":"Protection against the Omicron variant from previous SARS-CoV-2 infection","volume":"386","author":"Altarawneh","year":"2022","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.jinf.2023.10.022_bib7","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection","volume":"386","author":"Hall","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jinf.2023.10.022_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jamainternmed.2021.7382","article-title":"Odds of testing positive for SARS-CoV-2 following receipt of 3 vs 2 doses of the BNT162b2 mRNA vaccine","volume":"182","author":"Patalon","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.jinf.2023.10.022_bib9","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/infdis\/jiac161","article-title":"Protection by vaccines and previous infection against the Omicron variant of severe acute respiratory syndrome Coronavirus 2","volume":"226","author":"\u0160m\u00edd","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2023.10.022_bib10","article-title":"Neutralization and Stability of SARS-CoV-2 Omicron Variant","author":"Zeng","year":"2021","journal-title":"bioRxiv"},{"issue":"10318","key":"10.1016\/j.jinf.2023.10.022_bib11","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0140-6736(21)02717-3","article-title":"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial","volume":"398","author":"Munro","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jinf.2023.10.022_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jinf.2023.10.022_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41591-022-01705-6","article-title":"Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination","volume":"28","author":"Perez-Then","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jinf.2023.10.022_bib14","unstructured":"JCVI. JCVI advice on the UK vaccine response to the Omicron variant; 2021. \u3008https:\/\/www.gov.uk\/government\/publications\/uk-vaccine-response-to-the-omicron-variant-jcvi-advice\/jcvi-advice-on-the-uk-vaccine-response-to-the-omicron-variant\u3009. Accessed 01\/02\/2023."},{"issue":"6582","key":"10.1016\/j.jinf.2023.10.022_bib15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.abn7760","article-title":"SARS-CoV-2 Omicron variant: antibody evasion and cryo-EM structure of spike protein-ACE2 complex","volume":"375","author":"Mannar","year":"2022","journal-title":"Science"},{"issue":"7898","key":"10.1016\/j.jinf.2023.10.022_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jinf.2023.10.022_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054336","article-title":"Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers - the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol","volume":"12","author":"Wallace","year":"2022","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.jinf.2023.10.022_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.2022.0470","article-title":"Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants","volume":"327","author":"Accorsi","year":"2022","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.jinf.2023.10.022_bib19","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"issue":"10316","key":"10.1016\/j.jinf.2023.10.022_bib20","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2023.10.022_bib21","article-title":"Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: a Danish cohort study","author":"Hansen","year":"2021","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.jinf.2023.10.022_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jinf.2023.04.012","article-title":"Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial","volume":"87","author":"Liu","year":"2023","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jinf.2023.10.022_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3201\/eid2901.221293","article-title":"Early warning surveillance for SARS-CoV-2 Omicron variants, United Kingdom, November 2021-September 2022","volume":"29","author":"Foulkes","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"637","key":"10.1016\/j.jinf.2023.10.022_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn8057","article-title":"Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection","volume":"14","author":"Evans","year":"2022","journal-title":"Sci Transl Med"},{"issue":"10292","key":"10.1016\/j.jinf.2023.10.022_bib25","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(21)01290-3","article-title":"Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination","volume":"397","author":"Wall","year":"2021","journal-title":"Lancet"},{"issue":"7898","key":"10.1016\/j.jinf.2023.10.022_bib26","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","article-title":"Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization","volume":"602","author":"Cele","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jinf.2023.10.022_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/cid\/ciac392","article-title":"Understanding 'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines","volume":"76","author":"Epsi","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"78","key":"10.1016\/j.jinf.2023.10.022_bib28","doi-asserted-by":"crossref","first-page":"8328","DOI":"10.1126\/sciimmunol.abp8328","article-title":"Immune recall improves antibody durability and breadth to SARS-CoV-2 variants","volume":"7","author":"Chen","year":"2022","journal-title":"Sci Immunol"},{"issue":"5","key":"10.1016\/j.jinf.2023.10.022_bib29","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/v14051086","article-title":"Immune response 5-7 months after vaccination against SARS-CoV-2 in elderly nursing home residents in the Czech Republic: comparison of three vaccines","volume":"14","author":"Martinek","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.jinf.2023.10.022_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/imr.13089","article-title":"Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines","volume":"310","author":"Sette","year":"2022","journal-title":"Immunol Rev"},{"issue":"6549","key":"10.1016\/j.jinf.2023.10.022_bib31","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.abj2258","article-title":"Hybrid immunity","volume":"372","author":"Crotty","year":"2021","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jinf.2023.10.022_bib32","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cell.2022.01.011","article-title":"SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses","volume":"185","author":"Walls","year":"2022","journal-title":"Cell"},{"issue":"68","key":"10.1016\/j.jinf.2023.10.022_bib33","doi-asserted-by":"crossref","first-page":"eabn8014","DOI":"10.1126\/sciimmunol.abn8014","article-title":"Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants","volume":"7","author":"Bates","year":"2022","journal-title":"Sci Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2023.10.022_bib34","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2666-5247(21)00275-5","article-title":"T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study","volume":"3","author":"Angyal","year":"2022","journal-title":"Lancet Microbe"},{"issue":"577","key":"10.1016\/j.jinf.2023.10.022_bib35","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.jinf.2023.10.022_bib36","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.cell.2022.03.018","article-title":"Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity","volume":"185","author":"Rodda","year":"2022","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.jinf.2023.10.022_bib37","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/cid\/ciac378","article-title":"A Single Dose of BNT162b2 mRNA vaccine induces airway immunity in SARS-CoV-2 naive and recovered COVID-19 subjects","volume":"75","author":"Martinuzzi","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2023.10.022_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41392-022-01002-1","article-title":"Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants","volume":"7","author":"Lei","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jinf.2023.10.022_bib39","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268819001961","article-title":"Depletion-of-susceptibles bias in influenza vaccine waning studies: how to ensure robust results","volume":"147","author":"Lipsitch","year":"2019","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2023.10.022_bib40","article-title":"High rate of asymptomatic carriage associated with variant strain Omicron","author":"Garrett","year":"2022","journal-title":"medRxiv"},{"issue":"5","key":"10.1016\/j.jinf.2023.10.022_bib41","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/aje\/kwac015","article-title":"Identifying and alleviating bias due to differential depletion of susceptible people in postmarketing evaluations of COVID-19 vaccines","volume":"191","author":"Kahn","year":"2022","journal-title":"Am J Epidemiol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445323005534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445323005534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:37:21Z","timestamp":1759009041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445323005534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0163445323005534"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2023.10.022","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.05.22.23290197","asserted-by":"object"}]},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of BNT162b2 mRNA vaccine third doses and previous infection in protecting against SARS-CoV-2 infections during the Delta and Omicron variant waves; the UK SIREN cohort study September 2021 to February 2022","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2023.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}